Antibody, reagent and kit for Kawasaki disease treatment effect evaluation and application of antibody, reagent and kit
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- DAOZHI PRECISION MEDICINE TECH SHANGHAI CO LTD
- Publication Date
- 2021-01-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to an antibody, reagent, kit and application thereof for evaluating the therapeutic effect of Kawasaki disease. Background technique
[0002] Kawasaki disease (KD) was first reported by Japanese pediatrician Tomisaku Kawasaki in 1967. It is an acute, self-limited systemic vasculitis. The main clinical manifestations are fever, oral mucosal changes, rash, and cervical lymph nodes. Swelling, bulbar conjunctival hyperemia and extremity changes. Coronary artery lesion (CAL) caused by KD mainly includes coronary artery dilatation, coronary aneurysm, and later development of coronary artery stenosis. In severe cases, myocardial infarction, ischemic cardiomyopathy, and even sudden death may occur.
[0003] my country has a large population base and a large number of children under the age of 5. It belongs to the Asian population with a high incidence of Kawasaki disease. In recent years, the ...